VASH2 and glioma: Knockdown of H19 has been revealed to inhibit glioma-induced angiogenesis and glioma-associated endothelial cell capabilities of proliferation, migration and tube formation by decreasing the expression of angiogenic factor vasohibin 2 through upregulation of miR-29a [33].